This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Apr 11;339(8798):909-12.

doi: 10.1016/0140-6736(92)90939-z.

Glutathione deficiency and human immunodeficiency virus infection

F J Staal¹, S W Ela, M Roederer, M T Anderson, L A Herzenberg, L A Herzenberg

Affiliations

PMID: 1348307
DOI: 10.1016/0140-6736(92)90939-z

Free article

Review

Glutathione deficiency and human immunodeficiency virus infection

F J Staal et al. Lancet. 1992.

Free article

. 1992 Apr 11;339(8798):909-12.

doi: 10.1016/0140-6736(92)90939-z.

Authors

F J Staal¹, S W Ela, M Roederer, M T Anderson, L A Herzenberg, L A Herzenberg

Affiliation

¹ Department of Genetics, Stanford University School of Medicine, California 94305.

PMID: 1348307
DOI: 10.1016/0140-6736(92)90939-z

No abstract available

PubMed Disclaimer

Comment in

Glutathione deficiency and HIV infection.
Robinson MK, Hong RW, Wilmore DW. Robinson MK, et al. Lancet. 1992 Jun 27;339(8809):1603-4. doi: 10.1016/0140-6736(92)91864-5. Lancet. 1992. PMID: 1351570 No abstract available.

Similar articles

Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine.
de Quay B, Malinverni R, Lauterburg BH. de Quay B, et al. AIDS. 1992 Aug;6(8):815-9. AIDS. 1992. PMID: 1418777
Glutathione redox disturbances in human immunodeficiency virus infection: immunologic and therapeutic consequences.
Aukrust P, Müller F. Aukrust P, et al. Nutrition. 1999 Feb;15(2):165-7. doi: 10.1016/s0899-9007(98)00156-7. Nutrition. 1999. PMID: 9990587 Review. No abstract available.
Systemic glutathione deficiency in symptom-free HIV-seropositive individuals.
Buhl R, Jaffe HA, Holroyd KJ, Wells FB, Mastrangeli A, Saltini C, Cantin AM, Crystal RG. Buhl R, et al. Lancet. 1989 Dec 2;2(8675):1294-8. doi: 10.1016/s0140-6736(89)91909-0. Lancet. 1989. PMID: 2574255
Quantitation of reduced glutathione and cysteine in human immunodeficiency virus-infected patients.
Sbrana E, Paladini A, Bramanti E, Spinetti MC, Raspi G. Sbrana E, et al. Electrophoresis. 2004 Jun;25(10-11):1522-9. doi: 10.1002/elps.200305848. Electrophoresis. 2004. PMID: 15188236
Cellular antioxidant status and human immunodeficiency virus replication.
Baker DH, Wood RJ. Baker DH, et al. Nutr Rev. 1992 Jan;50(1):15-8. doi: 10.1111/j.1753-4887.1992.tb02456.x. Nutr Rev. 1992. PMID: 1579264 Review.

See all similar articles

Cited by

New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.
Paquet P, Piérard GE. Paquet P, et al. Drug Saf. 2010 Mar 1;33(3):189-212. doi: 10.2165/11532540-000000000-00000. Drug Saf. 2010. PMID: 20158284
Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells.
Sung JH, Shin SA, Park HK, Montelaro RC, Chong YH. Sung JH, et al. J Neurovirol. 2001 Oct;7(5):454-65. doi: 10.1080/135502801753170318. J Neurovirol. 2001. PMID: 11582518
Reduced levels of reactive oxygen species correlate with inhibition of apoptosis, rise in thioredoxin expression and increased bovine leukemia virus proviral loads.
Bouzar AB, Boxus M, Florins A, François C, Reichert M, Willems L. Bouzar AB, et al. Retrovirology. 2009 Nov 10;6:102. doi: 10.1186/1742-4690-6-102. Retrovirology. 2009. PMID: 19903329 Free PMC article.
HIV-1, reactive oxygen species, and vascular complications.
Porter KM, Sutliff RL. Porter KM, et al. Free Radic Biol Med. 2012 Jul 1;53(1):143-59. doi: 10.1016/j.freeradbiomed.2012.03.019. Epub 2012 Apr 21. Free Radic Biol Med. 2012. PMID: 22564529 Free PMC article. Review.
Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.
Hong H, Dooley KE, Starbird LE, Francis HW, Farley JE. Hong H, et al. Arch Toxicol. 2019 May;93(5):1385-1399. doi: 10.1007/s00204-019-02407-8. Epub 2019 Apr 8. Arch Toxicol. 2019. PMID: 30963202 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

CA42509/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information